SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves quarterly results beat expectations and its raised outlook, backed by strong AI-cloud demand and a growing backlog, have fueled bullish sentiment and short-squeeze chatter. Traders remain divided over whether that growth can overcome heavy debt, interest costs, and capital spending to produce sustainable profits.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Reports about Jensen Huangs relationship with a woman described as a suspected Chinese spy, and questions about Nvidia chip shipments to China, have fueled concern over leadership, governance and national-security risks. Traders disagree on whether the controversy threatens the business or is a distraction from AI demand; many dip buyers point to CoreWeaves results and Nvidias upcoming earnings as reasons for optimism.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Traders are focused on the FDAs Nov. 22 decision on Capricors Duchenne therapy, Deramiocel; management reaffirmed confidence on its Q3 call and said the application is in final review. Many traders read the companys launch preparations and call remarks as encouraging, while others emphasize the binary approval risk, prior advisory-panel concerns, and unresolved NS Pharma dispute.

Agility Robotics, Inc. engages in the builds robot partners that augment the human workforce. The firm groundbreaking general-purpose humanoid robot, digit, is the first multi-purpose, human-centric robot that is made for work and commercially deployed today. The company is headquartered in Salem, OR.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Agility Robotics de-SPAC debut and its humanoid-robotics story are driving attention, with traders focused on Digit deployments, commercial orders and strategic ties to major technology companies. The community is split between enthusiasm for robotics growth and low-float or short-squeeze speculation, and concerns about SPAC risks, losses and the challenge of scaling the business.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMines reported paper losses on its Ethereum holdings amid ETHs decline, alongside continued accumulation, are drawing attention. Traders are divided between viewing the buying and discounted asset value as an opportunity and criticizing Tom Lees strategy, weak share performance, and lack of buybacks.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention ahead of its Q3 earnings report, with traders watching whether Northern Data/Quake AI revenue and the reported Anthropic compute agreement validate its AI-infrastructure pivot. Bulls point to elevated short interest and the possibility of a squeeze, while skeptics question financing, dilution and the companys ability to turn expansion into sustainable results.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of expected Q4 2026 Phase 3 APPROACH topline results for HLP003, its investigational depression treatment. Bulls emphasize its adjunctive trial design and potential for shorter clinic visits, while skeptics point to binary trial risk, possible dilution, and competition in psychedelic therapies.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars sharp selloff has traders focused on analyst concerns about limited 2026 booking visibility, alongside rising yields and uncertainty over solar policy and tax credits. Bulls call the decline an overreaction and point to the companys backlog, while bearish traders expect further weakness.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis quarterly results missed expectations and its revenue outlook came in below forecasts, fueling concern about weak commercial traction and the companys rich valuation. Traders are divided between those who see the earnings as evidence that commercialization remains distant and bulls who point to quantum-hardware progress and view the business as a long-term bet.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Positive Phase 2 results for AbCelleras ABCL635 hot-flash treatment, alongside better-than-expected quarterly results and substantial liquidity, are driving attention. Many traders see promise in the pipeline and potential partnering, while others stress that durability data and progress toward later-stage trials are still needed and point to volatile, sometimes disappointing price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
